Skip to content
Navigate to homepage - Cerba Research
Resource Library

Verdijk P, et al. First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity: a randomized controlled trial.

Resource Library

Neevel AMG, et al. Quantity vs. quality: an assessment of the current pipeline for rabies.

Resource Library

Okba NMA, et al. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV

Resource Library

Rockx B, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

Resource Library

Mu├▒oz-Fontela C, et al. Animal models for COVID-19.

Resource Library

Vink FJ, et al. FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study. Int J Cancer.

Resource Library

Tsang SH, et al. Durability of cross-protection by different schedulesof the bivalent HPV vaccine: the CVT trial.

Resource Library

Stratton P, et al. Immune response following quadrivalent human papillomavirus vaccination in women after hematopoietic allogeneic stem cell transplant: a nonrandomized clinical trial.

Resource Library

Porras C, et al. Efficacy of the bivalent HPV vaccine against HPV16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.

Resource Library

Leeman A, et al. Grading immunohistochemical markers p16INK4a and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions.